Titan's diverse landscapes as evidenced by Cassini RADAR's third and fourth looks at Titan

International audienceCassini's third and fourth radar flybys, T7 and T8, covered diverse terrains in the high southern and equatorial latitudes, respectively. The T7 synthetic aperture radar (SAR) swath is somewhat more straightforward to understand in terms of a progressive poleward descent from a high, dissected, and partly hilly terrain down to a low flat plain with embayments and deposits suggestive of the past or even current presence of hydrocarbon liquids. The T8 swath is dominated by dunes likely made of organic solids, but also contain somewhat enigmatic, probably tectonic, features that may be partly buried or degraded by erosion or relaxation in a thin crust. The dark areas in T7 show no dune morphology, unlike the dark areas in T8, but are radiometrically warm like the dunes. The Huygens landing site lies on the edge of the T8 swath; correlation of the radar and Huygens DISR images allows accurate determination of its coordinates, and indicates that to the north of the landing site sit two large longitudinal dunes. Indeed, had the Huygens probe trajectory been just 10 km north of where it actually was, images of large sand dunes would have been returned in place of the fluvially dissected terrain actually seen?illustrating the strong diversity of Titan's landscapes even at local scales

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010

<p>Abstract</p> <p>Background</p> <p>In France, it is estimated that 24% of HIV-infected patients are also infected with HCV. Longitudinal studies addressing clinical and public health questions related to HIV-HCV co-infection (HIV-HCV clinical progression and its determinants including genetic dimension, patients' experience with these two diseases and their treatments) are limited. The ANRS CO 13 HEPAVIH cohort was set up to explore these critical questions.</p> <p>To describe the cohort aims and organization, monitoring and data collection procedures, baseline characteristics, as well as follow-up findings to date.</p> <p>Methods</p> <p>Inclusion criteria in the cohort were: age > 18 years, HIV-1 infection, chronic hepatitis C virus (HCV) infection or sustained response to HCV treatment. A standardized medical questionnaire collecting socio-demographic, clinical, biological, therapeutic, histological, ultrasound and endoscopic data is administered at enrolment, then every six months for cirrhotic patients or yearly for non-cirrhotic patients. Also, a self-administered questionnaire documenting socio-behavioral data and adherence to HIV and/or HCV treatments is administered at enrolment and yearly thereafter.</p> <p>Results</p> <p>A total of 1,175 patients were included from January 2006 to December 2008. Their median age at enrolment was 45 years and 70.2% were male. The median CD4 cell count was 442 (IQR: 304-633) cells/μl and HIV RNA plasma viral load was undetectable in 68.8%. Most participants (71.6%) were on HAART. Among the 1,048 HIV-HCV chronically co-infected patients, HCV genotype 1 was predominant (56%) and cirrhosis was present in 25%. As of January, 2010, after a median follow-up of 16.7 months (IQR: 11.3-25.3), 13 new cases of decompensated cirrhosis, nine hepatocellular carcinomas and 20 HCV-related deaths were reported, resulting in a cumulative HCV-related severe event rate of 1.9/100 person-years (95% CI: 1.3-2.5). The rate of HCV-related severe events was higher in cirrhotic patients and those with a low CD4 cells count, but did not differ according to sex, age, alcohol consumption, CDC clinical stage or HCV status.</p> <p>Conclusion</p> <p>The ANRS CO 13 HEPAVIH is a nation-wide cohort using a large network of HIV treatment, infectious diseases and internal medicine clinics in France, and thus is highly representative of the French population living with these two viruses and in care.</p